Barinthus Biotherapeutics plc
BRNS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $51 | $38 | $39 | $48 |
| - Cash | $74 | $86 | $99 | $111 |
| + Debt | $12 | $12 | $12 | $12 |
| Enterprise Value | -$12 | -$37 | -$48 | -$51 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$13 | -$19 | -$18 | -$19 |
| % Margin | – | – | – | – |
| Net Income | -$15 | -$21 | -$20 | -$21 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.36 | -0.52 | -0.49 | -0.51 |
| % Growth | 30.8% | -6.1% | 3.9% | – |
| Operating Cash Flow | -$11 | -$18 | -$15 | $13 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$11 | -$18 | -$15 | $13 |